• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Virios Therapeutics Inc (NQ: VIRI )

    0.1550 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Oct 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Virios Therapeutics Inc

    < Previous 1 2 3 4 5 6 7 Next >
    Virios' Promising Fibromyalgia Treatment Candidate Expects September 2022 Phase 2b Results
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
      
    Via Benzinga
    Virios Therapeutics’ Study Featured in Peer-Reviewed Journal Publication Highlighting Association of Herpes Simplex Type 1 Viral Infection with Common Gastrointestinal Disorders, Including in Patients with Comorbid Fibromyalgia
    From Virios Therapeutics, Inc.
    Via Business Wire
    Virios Therapeutics: Q1 Earnings Insights
    Virios Therapeutics (NASDAQ:VIRI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Earnings Scheduled For November 11, 2021
    Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... 
    Via Benzinga
    Virios Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
    From Virios Therapeutics, Inc.
    Via Business Wire
    Preview: Virios Therapeutics's Earnings
    Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Virios... 
    Via Benzinga
    Virios Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on Thursday, May 12, 2022
    From Virios Therapeutics, Inc.
    Via Business Wire
    Earnings Scheduled For May 12, 2022
    Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. 
    Via Benzinga
    Virios Therapeutics Completes Enrollment of 425 Patients in Phase 2b “FORTRESS” Clinical Trial for Fibromyalgia
    From Virios Therapeutics, Inc. (VIRI)
    Via Business Wire
    Virios Therapeutics: Q4 Earnings Insights
    Virios Therapeutics (NASDAQ:VIRI) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... 
    Via Benzinga
    Virios Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
    From Virios Therapeutics, Inc.
    Via Business Wire
    Earnings Scheduled For March 17, 2022
    Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is... 
    Via Benzinga
    A Preview Of Virios Therapeutics's Earnings
    Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts... 
    Via Benzinga
    Virios Therapeutics Announces Research Collaboration Exploring the Potential of Combination Antiviral Therapy for Treating Long COVID
    From Virios Therapeutics, Inc. (VIRI)
    Via Business Wire
    An Innovative Approach To Antiviral Therapies And Treating Fibromyalgia (FM) Disease?
    Photo by Fusion Medical Animation on Unsplash Greg Duncan, Chairman and CEO of Virios Therapeutics Inc. (NASDAQ: VIRI), was a guest speaker at Benzinga’s All Access on Jan. 28, 2022. 
    Via Benzinga
    Benzinga Announces This Week's All Access Guests
    Benzinga is thrilled to announce the guest lineup for our next All Access show, presented by RedChip, set to air Friday, January 28 at 9:15 am ET. The Lineup 9:15 am:... 
    Via Benzinga
    RedChip Partners with Benzinga to Host Exclusive Small-Cap CEO Interview Series on January 28
    ORLANDO, FL / ACCESSWIRE / January 26, 2022 / RedChip Companies, Inc., an international investor relations, media, and research firm focused on microcap and small-cap companies, is pleased to announce... 
    From RedChip
    Via AccessWire
    Virios Therapeutics to Present at the Virtual H.C. Wainwright BioConnect Conference
    From Virios Therapeutics, Inc. (VIRI)
    Via Business Wire
    Virios Therapeutics Achieves Over 50% Enrollment Milestone in its Phase 2b Clinical Trial for Fibromyalgia
    From Virios Therapeutics, Inc. (VIRI)
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
    Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE: 
    Via Benzinga
    Virios Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update
    From Virios Therapeutics, Inc. (VIRI)
    Via Business Wire
    Virios Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on Thursday, November 11, 2021
    From Virios Therapeutics, Inc. (VIRI)
    Via Business Wire
    Virios Therapeutics Granted New Patent for Antiviral Inhibitor Combination
    From Virios Therapeutics, Inc.
    Via Business Wire
    64 Biggest Movers From Yesterday
    Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on... 
    Via Benzinga
    Virios Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
    From Virios Therapeutics, Inc. (VIRI)
    Via Business Wire
    Stocks That Hit 52-Week Lows On Friday
    On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-... 
    Via Benzinga
    Virios Therapeutics Announces New Social Media Profiles
    From Virios Therapeutics, Inc.
    Via Business Wire
    Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
    LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be... 
    From Stock News Now
    Via AccessWire
    Topics Cannabis
    Exposures Cannabis
    Virios Therapeutics CEO Highlights Novel Therapeutic Approach for Treating Fibromyalgia and Irritable Bowel Syndrome in Stock News Now Video Interview
    From Virios Therapeutics, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.